Metraipolis › archive › dc_6766d953fa03

Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42221032
DOI
10.3389/fnagi.2026.1843643
License (as archived)
solo-consultazione
Archived
2026-11-01T16:55:31.885Z
SHA-256 of the archived text
041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4
Stable URL of this page
https://metraipolis.com/documento/dc_6766d953fa03

How to cite

Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032 — Europe PMC (en), https://europepmc.org/article/MED/42221032 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6766d953fa03 (Metraipolis archive dc_6766d953fa03, sha256 041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4)
BibTeX
@misc{dc6766d953fa03,
  title = {Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting — Europe PMC PMID:42221032},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42221032},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6766d953fa03; sha256 041da60815318ccd3b424dff27a8960e7d8e74fc6ff7db1837abd0fa1bd437f4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42221032. Agents can read the archived copy with the MCP tool read_document.